Intellectual Property

As a pioneer in the field of exosome therapeutics Evox has established an impressive foundational portfolio of intellectual property. Evox prides itself on having created a comprehensive IP portfolio encompassing all key aspects of exosome-based drug delivery technology.

Evox’s IP Portfolio:

Cargo loading technology

Cargo loading technology

RNA, gene-editing and protein replacement cargos

Manufacturing and purification methods

Manufacturing and purification methods

Cellular engineering technology, upstream optimization and downstream processing, analytics and quality control

Pharmacokinetics & pharmacodynamics

Pharmacokinetics & pharmacodynamics

Half-life extension

Targeting and release technologies

Targeting and release technologies

Bioactive release and organ targeting

The Evox IP portfolio includes granted and pending applications in all major pharmaceutical markets, including USA, Europe, Japan, China and Korea as well as many other jurisdictions.  In addition, trade-secrets, know-how, copyrights and trademarks complete a broad and deep protection for the company’s intellectual assets.

We are always looking for opportunities to complement our growing IP estate through licensing.